메뉴 건너뛰기




Volumn 25, Issue 6, 2004, Pages 613-619

On the generation and ownership of alpha in medical studies

Author keywords

Alpha; Medical studies; Researchers

Indexed keywords

ACETYLSALICYLIC ACID; PLANT EXTRACT;

EID: 9944223310     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2004.07.006     Document Type: Note
Times cited : (28)

References (16)
  • 1
    • 0033028363 scopus 로고    scopus 로고
    • Detecting selection bias in randomized clinical trials
    • V.W. Berger, and D.V. Exner Detecting selection bias in randomized clinical trials Control. Clin. Trials 20 1999 319 327
    • (1999) Control. Clin. Trials , vol.20 , pp. 319-327
    • Berger, V.W.1    Exner, D.V.2
  • 2
    • 0345153663 scopus 로고
    • Influence of selection bias on type I error rate under random permuted block designs
    • M. Proschan Influence of selection bias on type I error rate under random permuted block designs Stat. Sin. 4 1994 219 231
    • (1994) Stat. Sin. , vol.4 , pp. 219-231
    • Proschan, M.1
  • 3
    • 0035218013 scopus 로고    scopus 로고
    • Trials within trials: Confirmatory subgroup analyses in controlled clinical experiments
    • L.A. Moye, and A. Deswal Trials within trials: confirmatory subgroup analyses in controlled clinical experiments Control. Clin. Trials 22 2001 605 619
    • (2001) Control. Clin. Trials , vol.22 , pp. 605-619
    • Moye, L.A.1    Deswal, A.2
  • 4
    • 0034732875 scopus 로고    scopus 로고
    • Pros and cons of permutation tests in clinical trials
    • V.W. Berger Pros and cons of permutation tests in clinical trials Stat. Med. 19 2000 1319 1328
    • (2000) Stat. Med. , vol.19 , pp. 1319-1328
    • Berger, V.W.1
  • 6
    • 0345701538 scopus 로고    scopus 로고
    • Controlling type I error rate for fast track drug development programmes
    • W.J. Shih, P. Ouyang, H. Quan, Y. Lin, B. Michiels, and L. Bijnens Controlling type I error rate for fast track drug development programmes Stat. Med. 22 2003 665 675
    • (2003) Stat. Med. , vol.22 , pp. 665-675
    • Shih, W.J.1    Ouyang, P.2    Quan, H.3    Lin, Y.4    Michiels, B.5    Bijnens, L.6
  • 7
    • 0038137094 scopus 로고    scopus 로고
    • Notice of duplicate publication
    • G.D. Curfman, S. Morrissey, and J.M. Drazen Notice of duplicate publication NEJM 348 22 2003 2254
    • (2003) NEJM , vol.348 , Issue.22 , pp. 2254
    • Curfman, G.D.1    Morrissey, S.2    Drazen, J.M.3
  • 8
    • 0037449502 scopus 로고    scopus 로고
    • When can a clinical trial be called "randomized"?
    • V.W. Berger, and J.D. Bears When can a clinical trial be called "randomized"? Vaccine 2003 468 472
    • (2003) Vaccine , pp. 468-472
    • Berger, V.W.1    Bears, J.D.2
  • 10
    • 0025222241 scopus 로고
    • Statistics in nonrandomized studies
    • K.J. Rothman Statistics in nonrandomized studies Epidemiology 1 6 1990 417 418
    • (1990) Epidemiology , vol.1 , Issue.6 , pp. 417-418
    • Rothman, K.J.1
  • 11
    • 0025221769 scopus 로고
    • Randomization, statistics, and causal inference
    • S. Greenland Randomization, statistics, and causal inference Epidemiology 1 6 1990 421 429
    • (1990) Epidemiology , vol.1 , Issue.6 , pp. 421-429
    • Greenland, S.1
  • 12
    • 3543007536 scopus 로고    scopus 로고
    • Randomization technique, allocation concealment, masking, and susceptibility of trials to selection bias
    • V.W. Berger, and C.A. Christophi Randomization technique, allocation concealment, masking, and susceptibility of trials to selection bias J. Mod. Appl. Stat. Methods 2 1 2003 80 86
    • (2003) J. Mod. Appl. Stat. Methods , vol.2 , Issue.1 , pp. 80-86
    • Berger, V.W.1    Christophi, C.A.2
  • 13
    • 0037356485 scopus 로고    scopus 로고
    • Challenges posed by the precautionary principle and accountability in ecological risk assessment
    • H. Matsuda Challenges posed by the precautionary principle and accountability in ecological risk assessment EnvironMetrics 14 2003 245 254
    • (2003) EnvironMetrics , vol.14 , pp. 245-254
    • Matsuda, H.1
  • 14
    • 0037905488 scopus 로고    scopus 로고
    • Clinical trials and rare diseases
    • S.W. Lagakos Clinical trials and rare diseases NEJM 348 2003 24
    • (2003) NEJM , vol.348 , pp. 24
    • Lagakos, S.W.1
  • 15
    • 0042742904 scopus 로고
    • Posterior predictive p-values
    • X.L. Meng Posterior predictive p-values Ann. Stat. 22 3 1994 1142 1160
    • (1994) Ann. Stat. , vol.22 , Issue.3 , pp. 1142-1160
    • Meng, X.L.1
  • 16
    • 0037386051 scopus 로고    scopus 로고
    • Direct effect on validity of response run-in selection in clinical trials
    • V.W. Berger, A. Rezvani, and V. Makarewicz Direct effect on validity of response run-in selection in clinical trials Control. Clin. Trials 24 2 2003 156 166
    • (2003) Control. Clin. Trials , vol.24 , Issue.2 , pp. 156-166
    • Berger, V.W.1    Rezvani, A.2    Makarewicz, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.